Swampscott, MA, United States of America

Neil Kubica

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Neil Kubica: Innovator in RNA Research

Introduction

Neil Kubica is a prominent inventor based in Swampscott, MA (US). He has made significant contributions to the field of RNA research, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance our understanding of RNA and its applications in drug discovery.

Latest Patents

Kubica's latest patents include "TREM compositions and uses thereof" and "Nucleic acid-binding photoprobes and uses thereof." The first invention relates to tRNA-based effector molecules that feature a non-naturally occurring modification, along with methods associated with these molecules. The second patent involves photoactivatable compounds and methods for determining binding sites and structural information about RNA transcripts. This invention also outlines methods for identifying RNA transcripts that bind to compounds, which can be targeted for drug development.

Career Highlights

Throughout his career, Neil Kubica has worked with notable companies such as Flagship Pioneering Innovations and Arrakis Therapeutics, Inc. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Kubica has collaborated with esteemed colleagues, including Theonie Anastassiadis and David Charles Donnell Butler. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Neil Kubica's innovative work in RNA research and his contributions through his patents highlight his role as a key figure in the field. His ongoing efforts continue to pave the way for advancements in drug discovery and RNA technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…